ArticleThe Journal of infection2021

In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy.

Linda Petrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.